Genome-wide microRNA Expression Profiling in Primary Tumors and Matched Liver Metastasis of Patients with Colorectal Cancer
- PMID: 27365381
Genome-wide microRNA Expression Profiling in Primary Tumors and Matched Liver Metastasis of Patients with Colorectal Cancer
Abstract
Background: Primary tumor spread to the liver is the major cause of disease progression and death in patients with colorectal cancer (CRC). MicroRNAs (miRNAs) are small non-coding RNAs that are involved in cancer development and progression, but their role in metastasis has not been extensively investigated.
Materials and methods: Firstly, expression profiling of 752 miRNAs in 20 primary tumors and their corresponding liver metastases was performed. Secondly, validation of the results was carried out on an independent cohort of 66 patients with metastatic CRC using reverse transcription-quantitative polymerase chain (RT-qPCR) reaction.
Results: In total, 33 miRNAs were found to be significantly deregulated in liver metastases compared to their primary tumors. Fifteen miRNAs were chosen for subsequent validation, which confirmed significantly reduced expression of miR-143, miR 10b, and miR-28-5p, and increased expression of miR 122, miR-122*, and miR 885-5p in the tissue of liver metastases.
Conclusion: These results indicate that miRNAs could serve as new therapeutic targets in patients with metastatic CRC.
Keywords: Colorectal cancer; liver metastasis; microRNA.
Copyright© 2016, International Institute of Anticancer Research (Dr. John G. Delinasios), All rights reserved.
Similar articles
-
Differential microRNA expression profiling in primary tumors and matched liver metastasis of patients with colorectal cancer.Oncotarget. 2017 May 30;8(22):35783-35791. doi: 10.18632/oncotarget.16206. Oncotarget. 2017. PMID: 28415758 Free PMC article.
-
A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on Survival.Int J Mol Sci. 2016 Oct 21;17(10):1755. doi: 10.3390/ijms17101755. Int J Mol Sci. 2016. PMID: 27775664 Free PMC article.
-
MicroRNA expression profiles in human colorectal cancers with liver metastases.Oncol Rep. 2011 Mar;25(3):739-47. doi: 10.3892/or.2010.1112. Epub 2010 Dec 20. Oncol Rep. 2011. PMID: 21174058
-
The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment.Acta Biochim Pol. 2012;59(4):467-74. Epub 2012 Nov 21. Acta Biochim Pol. 2012. PMID: 23173124 Review.
-
Role of MicroRNA in the Diagnosis and Therapy of Hepatic Metastases from Colorectal Cancer.Microrna. 2018;7(3):167-177. doi: 10.2174/2211536607666180525073302. Microrna. 2018. PMID: 29793419 Review.
Cited by
-
Multilevel Heterogeneity of Colorectal Cancer Liver Metastasis.Cancers (Basel). 2023 Dec 21;16(1):59. doi: 10.3390/cancers16010059. Cancers (Basel). 2023. PMID: 38201487 Free PMC article. Review.
-
Investigating genomic, proteomic, and post-transcriptional regulation profiles in colorectal cancer: a comparative study between primary tumors and associated metastases.Cancer Cell Int. 2023 Sep 5;23(1):192. doi: 10.1186/s12935-023-03020-7. Cancer Cell Int. 2023. PMID: 37670299 Free PMC article.
-
Analysis of MicroRNA Expression Changes During the Course of Therapy In Rectal Cancer Patients.Front Oncol. 2021 Sep 2;11:702258. doi: 10.3389/fonc.2021.702258. eCollection 2021. Front Oncol. 2021. PMID: 34540669 Free PMC article.
-
Emerging Mechanisms and Treatment Progress on Liver Metastasis of Colorectal Cancer.Onco Targets Ther. 2021 May 6;14:3013-3036. doi: 10.2147/OTT.S301371. eCollection 2021. Onco Targets Ther. 2021. PMID: 33986602 Free PMC article. Review.
-
Therapeutic Approaches for Metastases from Colorectal Cancer and Pancreatic Ductal Carcinoma.Pharmaceutics. 2021 Jan 14;13(1):103. doi: 10.3390/pharmaceutics13010103. Pharmaceutics. 2021. PMID: 33466892 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical